 This systematic review found that interferon, IFN, does not appear to be effective in treating COVID-19 in patients with moderate or severe disease. However, it may be beneficial in patients with mild disease or at an earlier stage. Further research is needed to determine if IFN can be used safely and effectively in these populations. This article was authored by Sanjian Raiyu, Dehiapco, Suyanyu, and others.